LDL-cholesterol levels in patients with coronary heart disease receiving lipid-lowering therapy: Relation to pretreatment LDL-cholesterol and CHD risk status (reality study, Germany)

被引：0
|
作者：
Krobot, KJ
Yin, D
Alemao, E
Steinhagen-Thiessen, E
机构：
[1] MSD Sharp & Dohme GMBH, Haar, Germany
[2] Humboldt Univ, Charite, Berlin, Germany
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
下载
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [11] LDL-CHOLESTEROL TARGETS IN PATIENTS WITH CORONARY HEART DISEASE IN EXTREMADURA: LYNX REGISTRY
    Gomez-Barrado, J. J.
    Gomez-Turegano, P.
    Vega Fernandez, J.
    Porras Ramos, Y.
    Ortiz Cortes, C.
    Mogollon Jimenez, M. V.
    Kounka, Z.
    Lezcano Gort, L. E.
    Romero Castro, M. J.
    Chipayo Gonzales, D.
    Perez-Espejo, P.
    Roque Rodriguez, B.
    Fernandez-Chamorro, A. I.
    Beltran Moreno, M.
    ATHEROSCLEROSIS, 2020, 315 : E194 - E195
  • [12] Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: A population-based cohort study
    Sundboll, Jens
    Larsen, Anders Peter
    Veres, Katalin
    Adelborg, Kasper
    Sorensen, Henrik Toft
    THROMBOSIS RESEARCH, 2019, 183 : 124 - 130
  • [13] BEYOND LDL-CHOLESTEROL REDUCTION: EFFECT OF EZETIMIBE IN COMBINATION WITH ATORVASTATIN ON OXIDIZED LDL-CHOLESTEROL IN PATIENTS WITH CORONARY ARTERY DISEASE OR CORONARY ARTERY DISEASE EQUIVALENT
    Azar, Rabih R.
    Badaoui, Georges
    Sarkis, Antoine
    Azar, Mireille
    Aydanian, Hermine
    Harb, Serge
    Achkouty, Guy
    Kassab, Roland
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [14] Changes in LDL-cholesterol levels and lipid lowering therapy in primary care between 2002 and 2006. The REALITY studies
    Laforest, Laurent
    Souchet, Thierry
    DeSamericq, Gaelle
    Ritleng, Cecile
    Moulin, Philippe
    Kieffer, Alexia
    Le Jeunne, Philippe
    Van Ganse, Eric
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S153 - S153
  • [15] Small dense LDL-cholesterol concentrations are more powerful marker than LDL-cholesterol to predict coronary events in stable ischernic heart disease
    Koba, S.
    Yokota, Y.
    Tsunoda, F.
    Ban, Y.
    Sato, R.
    Sato, T.
    Suzuki, H.
    Geshi, E.
    Katagiri, T.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A115 - A115
  • [16] LDL-cholesterol is not the best blood lipid predictor of CHD risk in type 2 diabetes
    Eliasson, B.
    Gudbjornsdottir, S.
    Eeg-Olofsson, K.
    Svensson, A. -M.
    Zethelius, B.
    Cederholm, J.
    DIABETOLOGIA, 2010, 53
  • [17] METABOLIC DYSLIPIDEMIA AND RISK OF CORONARY HEART DISEASE IN ADULTS WITH DIABETES AND LOW LDL-CHOLESTEROL
    Rana, Jamal S.
    Liu, Jennifer Y.
    Moffet, Howard H.
    Solomon, Matthew
    Go, Alan S.
    Jaffe, Marc
    Karter, Andrew J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1341 - A1341
  • [18] Clinical Significance of Intensive Lipid-Lowering Therapy Using Statins in Patients With Coronary Artery Disease - LDL-Cholesterol: The Lower, the Better; Is It True for Asians? (Pro) -
    Miyauchi, Katsumi
    Daida, Hiroyuki
    CIRCULATION JOURNAL, 2010, 74 (08) : 1718 - 1730
  • [19] BASELINE LDL-CHOLESTEROL LEVELS AND OUTCOME IN PATIENTS WITH SEVERE HEART FAILURE
    Charach, G.
    Rogowsky, O.
    Weksler, D.
    Sheps, D.
    Keren, G.
    George, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 86 - 86
  • [20] Lipid-lowering Therapy and LDL Cholesterol in Patients after acute Coronary Syndrome
    Haider, P.
    Galli, L.
    Schrutka, L.
    Distelmaier, K.
    Wojta, J.
    Hengstenberg, C.
    Krychtiuk, K.
    Speidl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S419 - S419
12345